{"id":"artificial-tear-therapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Transient blurred vision"},{"rate":null,"effect":"Eye irritation or stinging"},{"rate":null,"effect":"Allergic reaction (rare)"}]},"_chembl":{"chemblId":"CHEMBL4298181","moleculeType":"Gene"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Artificial tears are topical ophthalmic solutions formulated to mimic the composition and function of natural tears, providing lubrication and protection to the cornea and conjunctiva. They help restore the tear film barrier, reduce friction during blinking, and alleviate discomfort associated with insufficient tear production or poor tear quality. The formulations typically contain water, electrolytes, and mucomimetic or viscosity-enhancing agents.","oneSentence":"Artificial tear therapy replaces or supplements the eye's natural tear film to lubricate the ocular surface and relieve symptoms of dry eye disease.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:42:34.070Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye disease (keratoconjunctivitis sicca)"},{"name":"Ocular surface irritation and discomfort"}]},"trialDetails":[{"nctId":"NCT06299319","phase":"PHASE1","title":"Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2024-09-01","conditions":"Obsessive-Compulsive Disorder","enrollment":10},{"nctId":"NCT07243275","phase":"PHASE4","title":"SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease","status":"RECRUITING","sponsor":"Indiana University","startDate":"2026-02-18","conditions":"Dry Eye Disease (DED)","enrollment":260},{"nctId":"NCT06544694","phase":"PHASE3","title":"A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2024-10-08","conditions":"Dry Eye Disease","enrollment":80},{"nctId":"NCT06365853","phase":"PHASE2","title":"A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-07-29","conditions":"Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive","enrollment":100},{"nctId":"NCT04149210","phase":"PHASE3","title":"FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial","status":"COMPLETED","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2021-08-19","conditions":"Trachomatous Trichiasis (TT), Eye Diseases, Eyelid Diseases","enrollment":2410},{"nctId":"NCT07490054","phase":"PHASE1","title":"Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure","status":"RECRUITING","sponsor":"Melana Yuzefpolskaya, MD","startDate":"2025-09-01","conditions":"Chronic Heart Failure","enrollment":40},{"nctId":"NCT05319730","phase":"PHASE1, PHASE2","title":"A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-05-16","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":230},{"nctId":"NCT02938520","phase":"PHASE3","title":"Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2016-10-27","conditions":"HIV Infections","enrollment":631},{"nctId":"NCT07482085","phase":"PHASE3","title":"Efavirenz for the Treatment of Creutzfeldt-Jakob Disease","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-03","conditions":"Creutzfeldt-Jakob Disease","enrollment":246},{"nctId":"NCT06089317","phase":"NA","title":"Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2024-07-28","conditions":"Dry Eye Syndromes","enrollment":200},{"nctId":"NCT05577910","phase":"NA","title":"Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2022-10-08","conditions":"Meibomian Gland Dysfunction","enrollment":374},{"nctId":"NCT06819046","phase":"","title":"Improved Efficacy of Selective Laser Trabeculoplasty With the Addition of Rocklatan Post-treatment vs Artificial Tears Post-treatment","status":"COMPLETED","sponsor":"Colorado Ophthalmology Associates PC","startDate":"2025-02-14","conditions":"Glaucoma","enrollment":70},{"nctId":"NCT06660290","phase":"PHASE3","title":"A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2025-01-15","conditions":"Dry Eye Disease","enrollment":55},{"nctId":"NCT06792903","phase":"EARLY_PHASE1","title":"YM-101 Eye Drops in the Treatment of Dry Eye Syndrome","status":"COMPLETED","sponsor":"Eye & ENT Hospital of Fudan University","startDate":"2024-04-23","conditions":"Dry Eye","enrollment":30},{"nctId":"NCT07224529","phase":"PHASE4","title":"Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-04-01","conditions":"Meibomian Gland Dysfunction (MGD)","enrollment":48},{"nctId":"NCT07471659","phase":"NA","title":"Effect of Daily Humiome® Post LB Intake on Wellbeing in Older Individuals With Moderate Stress Levels","status":"NOT_YET_RECRUITING","sponsor":"dsm-firmenich Switzerland AG","startDate":"2026-03-01","conditions":"Stress","enrollment":200},{"nctId":"NCT07284381","phase":"PHASE3","title":"A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-12-15","conditions":"Dry Eye Disease","enrollment":250},{"nctId":"NCT07469865","phase":"NA","title":"Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST)","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2021-11-30","conditions":"Dry Eye Disease","enrollment":46},{"nctId":"NCT05425004","phase":"PHASE2","title":"Cabozantinib for Patients With Recurrent or Progressive Meningioma","status":"RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2022-06-01","conditions":"Meningioma","enrollment":24},{"nctId":"NCT05692739","phase":"PHASE4","title":"Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye","status":"COMPLETED","sponsor":"Barbara Burgos Blasco","startDate":"2022-10-19","conditions":"Dry Eye, Insulin","enrollment":116},{"nctId":"NCT07422259","phase":"NA","title":"Tolerability and Efficacy Study of Reinnerva/Lubristil+G vs Vismed","status":"COMPLETED","sponsor":"Medivis SRL","startDate":"2025-06-09","conditions":"Keratoconjunctivitis Sicca","enrollment":40},{"nctId":"NCT07109869","phase":"PHASE3","title":"Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis","status":"RECRUITING","sponsor":"pH-D Feminine Health LLC","startDate":"2025-08-08","conditions":"Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital, Vulvovaginal Candidiasis (VVC)","enrollment":400},{"nctId":"NCT07413172","phase":"PHASE2","title":"Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"University of Miami","startDate":"2026-03","conditions":"Dry Eye, Eye Diseases, Eyes Dry Chronic","enrollment":20},{"nctId":"NCT06631586","phase":"PHASE2","title":"Standardized Microbiota Transplant Therapy in Crohn's Disease","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2025-01-15","conditions":"Crohn Disease","enrollment":120},{"nctId":"NCT06045494","phase":"NA","title":"The Efficacy of Treatment for Helicobacter Pylori Infection in Preschooler by Yoghurt With LG21","status":"COMPLETED","sponsor":"Meiji China Investment Co.,Ltd","startDate":"2023-09-26","conditions":"H. Pylori Infection","enrollment":140},{"nctId":"NCT07382453","phase":"PHASE2","title":"Effect of PAE Hydrogel Loaded With tRF-ASO-Exo on Patients With Diabetic Ocular Surface Diseases","status":"NOT_YET_RECRUITING","sponsor":"Affiliated Hospital of Nantong University","startDate":"2026-02-15","conditions":"Diabetic Keratopathy","enrollment":30},{"nctId":"NCT07041814","phase":"PHASE2","title":"A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRIFECTA-DARED Approach for Rare Diseases","status":"NOT_YET_RECRUITING","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2026-02-15","conditions":"Turner Syndrome","enrollment":24},{"nctId":"NCT06213649","phase":"PHASE3","title":"Parasitic Ulcer Treatment Trial","status":"RECRUITING","sponsor":"Jeremy Keenan, MD, MPH","startDate":"2024-07-01","conditions":"Acanthamoeba Keratitis","enrollment":232},{"nctId":"NCT06366087","phase":"PHASE1","title":"Sublingual Atropine Bioequivalence by Route of Administration (SABER)","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2024-04-15","conditions":"Atropine Bioequivalence","enrollment":46},{"nctId":"NCT06428409","phase":"PHASE1, PHASE2","title":"A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-06-20","conditions":"Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer","enrollment":220},{"nctId":"NCT04505566","phase":"PHASE1","title":"INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stephen J. Kim, MD","startDate":"2020-11-09","conditions":"Diabetic Retinopathy","enrollment":164},{"nctId":"NCT06163989","phase":"NA","title":"Protecting the Eyes of Gamers With Lubricating Eyedrops","status":"RECRUITING","sponsor":"Aston University","startDate":"2024-09-01","conditions":"Dry Eye Syndromes, Computer Vision Syndrome","enrollment":28},{"nctId":"NCT03697876","phase":"PHASE1","title":"Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2018-08-20","conditions":"Dry Eye Syndromes","enrollment":32},{"nctId":"NCT03471143","phase":"PHASE1, PHASE2","title":"Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-02-22","conditions":"Niemann-Pick Disease, Type C","enrollment":4},{"nctId":"NCT06308653","phase":"PHASE3","title":"Psilocybin for Major Depressive Disorder (MDD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Usona Institute","startDate":"2024-03-13","conditions":"Depressive Disorder, Major","enrollment":240},{"nctId":"NCT05632562","phase":"EARLY_PHASE1","title":"Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2024-03-07","conditions":"High Grade Glioma","enrollment":20},{"nctId":"NCT05106127","phase":"PHASE2","title":"Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem","status":"NOT_YET_RECRUITING","sponsor":"Evergreen Therapeutics, Inc.","startDate":"2026-08","conditions":"Advanced Endometrial Cancer","enrollment":28},{"nctId":"NCT06223685","phase":"NA","title":"The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin","status":"COMPLETED","sponsor":"Pomeranian Medical University Szczecin","startDate":"2023-04-01","conditions":"Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth, SIBO","enrollment":129},{"nctId":"NCT05249556","phase":"PHASE3","title":"Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old","status":"NOT_YET_RECRUITING","sponsor":"Immedica Pharma AB","startDate":"2026-06","conditions":"CDKL5 Deficiency Disorder","enrollment":20},{"nctId":"NCT06489340","phase":"PHASE2","title":"P2a Open Label Study to Evaluate 2-HPβCD in Subjects With Diabetic Kidney Disease","status":"WITHDRAWN","sponsor":"ZyVersa Therapeutics, Inc.","startDate":"2025-06-11","conditions":"Diabetic Kidney Disease","enrollment":""},{"nctId":"NCT06834984","phase":"NA","title":"Ritual Synbiotic+, a Dietary Supplement Designed to Impact Gastrointestinal Health, Mood, and Behavior in Women","status":"RECRUITING","sponsor":"Colorado State University","startDate":"2025-05-01","conditions":"Gastrointestinal Disease Symptoms","enrollment":60},{"nctId":"NCT07229001","phase":"NA","title":"Treating Meibomian Gland Disease in a Pediatric Population","status":"ENROLLING_BY_INVITATION","sponsor":"Illinois College of Optometry","startDate":"2024-10-01","conditions":"Dry Eye Disease, Meibomian Gland Disease","enrollment":15},{"nctId":"NCT04968912","phase":"PHASE2","title":"A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-09-21","conditions":"Sjogren's Syndrome","enrollment":163},{"nctId":"NCT05031897","phase":"PHASE2","title":"Two Step Haplo With Radiation Conditioning","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2021-10-25","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adult T-Cell Leukemia/Lymphoma","enrollment":63},{"nctId":"NCT01760655","phase":"PHASE2","title":"Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2012-12-24","conditions":"Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM","enrollment":62},{"nctId":"NCT05999630","phase":"PHASE3","title":"Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-08-21","conditions":"Nasolacrimal Duct Obstruction, Thyroid Cancer","enrollment":100},{"nctId":"NCT07078955","phase":"PHASE2","title":"A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease","status":"NOT_YET_RECRUITING","sponsor":"BRIM Biotechnology Inc.","startDate":"2025-12","conditions":"Dry Eye Disease (DED), Keratoconjunctivitis Sicca","enrollment":99},{"nctId":"NCT05800353","phase":"NA","title":"Nd:YAG Laser Vitreolysis for Symptomatic Vitreous Floaters","status":"COMPLETED","sponsor":"Dongyang People's Hospital","startDate":"2022-11-22","conditions":"Weiss Ring","enrollment":70},{"nctId":"NCT04440280","phase":"PHASE2","title":"Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy","status":"RECRUITING","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2020-09-16","conditions":"Fuchs Endothelial Corneal Dystrophy","enrollment":45},{"nctId":"NCT07181668","phase":"NA","title":"Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Femto-Lasik Surgery","status":"COMPLETED","sponsor":"Grigore T. Popa University of Medicine and Pharmacy","startDate":"2024-08-10","conditions":"Dry Eye, Meibomian Gland Dysfunction (Disorder), Ocular Surface Disease","enrollment":61},{"nctId":"NCT06191965","phase":"PHASE2, PHASE3","title":"MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction","status":"RECRUITING","sponsor":"Mclean Hospital","startDate":"2024-06-01","conditions":"Schizophrenia and Related Disorders, Mitochondrial Alteration, Cognitive Impairment","enrollment":100},{"nctId":"NCT06876077","phase":"NA","title":"Evaluation of the Effectiveness of Auricular Acupuncture in Improving Dry Eye Symptoms in University Students","status":"COMPLETED","sponsor":"University of Medicine and Pharmacy at Ho Chi Minh City","startDate":"2025-03-15","conditions":"Dry Eye Symptoms","enrollment":50},{"nctId":"NCT04125134","phase":"PHASE4","title":"Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2019-10-03","conditions":"Dry Eye","enrollment":36},{"nctId":"NCT07185854","phase":"NA","title":"Medical vs Acupuncture for Dry Eye","status":"COMPLETED","sponsor":"Nadide Koca","startDate":"2024-01-15","conditions":"Dry Eye, Acupuncture","enrollment":90},{"nctId":"NCT05542381","phase":"NA","title":"The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2022-12-22","conditions":"Age-Related Macular Degeneration","enrollment":64},{"nctId":"NCT05938699","phase":"PHASE2, PHASE3","title":"Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution","status":"COMPLETED","sponsor":"Nicox Ophthalmics, Inc.","startDate":"2023-12-12","conditions":"Open Angle Glaucoma","enrollment":18},{"nctId":"NCT03712878","phase":"PHASE2","title":"2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2018-09-19","conditions":"Hematopoietic and Lymphoid Cell Neoplasm","enrollment":10},{"nctId":"NCT06676917","phase":"PHASE2","title":"Datopotamab Deruxtecan (Dato-DXd) for Non-Small Cell Lung Cancer (NSCLC) Patients With Active Brain Metastases","status":"WITHDRAWN","sponsor":"MedSIR","startDate":"2025-06","conditions":"Non-small Cell Lung Cancer","enrollment":""},{"nctId":"NCT07064187","phase":"PHASE4","title":"Evaluate The Improvement In Symptoms Of Patients Using Cationorm After Pterygium Surgery","status":"COMPLETED","sponsor":"Nguyen Viet Giap","startDate":"2022-06-15","conditions":"Ocular Discomfort","enrollment":100},{"nctId":"NCT05954988","phase":"PHASE1","title":"A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients","status":"COMPLETED","sponsor":"Rein Therapeutics","startDate":"2023-07-06","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":24},{"nctId":"NCT05682547","phase":"NA","title":"Diquafosol vs Hyaluronic Acid for Diabetic Dry Eye","status":"COMPLETED","sponsor":"He Eye Hospital","startDate":"2022-12-01","conditions":"Diabetic Eye Problems","enrollment":99},{"nctId":"NCT05896670","phase":"PHASE2","title":"Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease","status":"COMPLETED","sponsor":"Oculis","startDate":"2023-11-29","conditions":"Dry Eye Disease","enrollment":122},{"nctId":"NCT06865144","phase":"PHASE4","title":"Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT","status":"RECRUITING","sponsor":"East Coast Institute for Research","startDate":"2025-06-27","conditions":"Primary Open Angle Glaucoma or Ocular Hypertension","enrollment":70},{"nctId":"NCT07027670","phase":"PHASE2","title":"Treatment With 5-AminoLEvuliNic Acid Before Cardiac Surgery","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2021-02-01","conditions":"Cardiac Surgical Procedures, Coronary Artery Bypass, Aortic Valve Disease","enrollment":48},{"nctId":"NCT07025980","phase":"PHASE2","title":"Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.","status":"NOT_YET_RECRUITING","sponsor":"Eva Cubric","startDate":"2025-07-01","conditions":"MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), Diabetes Mellitus, Hypertension","enrollment":114},{"nctId":"NCT07000565","phase":"NA","title":"The Effect of Eye Care With Artificial Tears and Normal Saline on Ocular Surface Disease in Mechanically Ventilated Pediatric Patients","status":"COMPLETED","sponsor":"Marmara University","startDate":"2024-11-01","conditions":"Ocular Surface Disease","enrollment":42},{"nctId":"NCT05035342","phase":"PHASE3","title":"Fecal Transplantation to Eradicate Colonizing Emergent Superbugs","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-01-11","conditions":"Enterobacteriaceae Infections, Fecal Microbiota Transplantation","enrollment":214},{"nctId":"NCT06911242","phase":"PHASE1","title":"A Comparison of the Pharmacokinetic Properties of ARN-75039 Tablets With Excipients to Neat ARN-75039 in Hydroxypropyl Methylcellulose (HPMC) Capsules in Healthy Adult Participants Under Fed Conditions","status":"COMPLETED","sponsor":"Arisan Therapeutics, Inc.","startDate":"2025-03-17","conditions":"Lassa Virus Infection","enrollment":16},{"nctId":"NCT04603924","phase":"PHASE2, PHASE3","title":"Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients","status":"COMPLETED","sponsor":"NeuroBo Pharmaceuticals Inc.","startDate":"2020-10-07","conditions":"COVID-19","enrollment":49},{"nctId":"NCT06969586","phase":"","title":"The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy","status":"ENROLLING_BY_INVITATION","sponsor":"University Hospital Dubrava","startDate":"2025-04-01","conditions":"Fuchs Endothelial Corneal Dystrophy, Cataract, Glaucoma","enrollment":50},{"nctId":"NCT06512220","phase":"PHASE2","title":"Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2025-04-21","conditions":"Treatment Resistant Depression","enrollment":12},{"nctId":"NCT06955585","phase":"NA","title":"Efficacy of Lipid-containing Artificial Tears in the Treatment of Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Sestre Milosrdnice","startDate":"2025-04-25","conditions":"Dry Eye Disease, Dry Eye, Dry Eye, Evaporative","enrollment":50},{"nctId":"NCT06543667","phase":"PHASE1","title":"Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye","status":"RECRUITING","sponsor":"Iran University of Medical Sciences","startDate":"2024-08-01","conditions":"Dry Eye Syndromes","enrollment":30},{"nctId":"NCT05710237","phase":"PHASE2","title":"Does Psilocybin Require Psychedelic Effects to Treat Depression?","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2023-07-01","conditions":"Treatment-resistant Depression","enrollment":60},{"nctId":"NCT06518720","phase":"PHASE2","title":"Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2025-04-01","conditions":"Treatment Resistant Depression, Chronic Pain","enrollment":16},{"nctId":"NCT06939959","phase":"PHASE4","title":"Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease.","status":"RECRUITING","sponsor":"Khyber Teaching Hospital","startDate":"2025-04-14","conditions":"Dry Eye, Insulin Sensitivity","enrollment":126},{"nctId":"NCT06355583","phase":"PHASE2","title":"Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2024-05-01","conditions":"Acute Lymphoblastic Leukaemia, Acute Leukemia of Ambiguous Lineage, Chronic Myeloid Leukemia","enrollment":50},{"nctId":"NCT06914232","phase":"NA","title":"Efficacy of Warm Compress Therapy in Enhancing Tear Film Quality and Reducing Postoperative DES","status":"ACTIVE_NOT_RECRUITING","sponsor":"Superior University","startDate":"2025-03-20","conditions":"Dry Eye Syndrome","enrollment":54},{"nctId":"NCT05879406","phase":"NA","title":"A Study to Evaluate the Efficacy and Safety of Clear Skin Formula on Mitigating Mild to Moderate Non-cystic Acne","status":"COMPLETED","sponsor":"Ablon Skin Institute Research Center","startDate":"2023-05-31","conditions":"Non-Cystic Acne","enrollment":40},{"nctId":"NCT06688630","phase":"NA","title":"Laser Acupuncture for Dry Eye Disease Due to Visual Display Terminal Use","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2024-12-27","conditions":"Dry Eye Syndromes","enrollment":45},{"nctId":"NCT05705518","phase":"PHASE4","title":"Artificial Tears, Tear Lipids and Tear Film Dynamics","status":"COMPLETED","sponsor":"University of California, Berkeley","startDate":"2023-01-30","conditions":"Dry Eye","enrollment":81},{"nctId":"NCT03786796","phase":"PHASE2","title":"Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2019-06-03","conditions":"Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer","enrollment":20},{"nctId":"NCT06851364","phase":"PHASE2","title":"Efficacy of 0.38% and 0.18% Sodium Hyaluronate Ocular Lubricants for Dry Eye in Adult Gazan Participants","status":"COMPLETED","sponsor":"International Islamic University Malaysia","startDate":"2022-10-30","conditions":"Dry Eye","enrollment":45},{"nctId":"NCT05743985","phase":"NA","title":"Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults","status":"COMPLETED","sponsor":"Formula30A LLC","startDate":"2022-08-01","conditions":"Health, Subjective, Inflammatory Response, Adverse Effect","enrollment":69},{"nctId":"NCT02707120","phase":"PHASE4","title":"Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis","status":"WITHDRAWN","sponsor":"Biotechnology Institute IMASD","startDate":"2018-01-04","conditions":"Neurotrophic Keratitis","enrollment":""},{"nctId":"NCT05273372","phase":"NA","title":"RESTORE ME -- RCT of Oxaloacetate on Improving Fatigue in ME/CFS","status":"COMPLETED","sponsor":"Terra Biological LLC","startDate":"2022-03-15","conditions":"Myalgic Encephalomyelitis, Chronic Fatigue Syndrome, Fatigue","enrollment":82},{"nctId":"NCT06798025","phase":"NA","title":"Three Different Modalities for Treatment of Inflammatory Punctal Stenosis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-07-20","conditions":"Modalities, Treatment, Inflammatory Punctal Stenosis","enrollment":60},{"nctId":"NCT06752278","phase":"NA","title":"Efficacy of Pilocarpine As a Secretagogue Versus Artificial Tears for the Treatment of Dry Eye","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2024-10-01","conditions":"Dry Eye Disease (DED)","enrollment":40},{"nctId":"NCT06726525","phase":"PHASE4","title":"Hydroxypropyl-methylcellulose and GlicoPro® Eyedrops in the Treatment of Dry Eye Disease: Clinical Study","status":"COMPLETED","sponsor":"University of Milan","startDate":"2024-02-03","conditions":"Dry Eye","enrollment":44},{"nctId":"NCT03031327","phase":"NA","title":"Safety and Efficacy of 2 Concentrations of Lubricin vs Sodium Hyaluronate in Ocular Discomfort After Refractive Surgery.","status":"COMPLETED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2017-06-17","conditions":"Ocular Discomfort","enrollment":30},{"nctId":"NCT06720428","phase":"NA","title":"Acupoint Therapy Device for Dry Eye","status":"COMPLETED","sponsor":"Shanghai 10th People's Hospital","startDate":"2021-01-01","conditions":"Dry Eye","enrollment":120},{"nctId":"NCT06188260","phase":"PHASE2","title":"Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease","status":"COMPLETED","sponsor":"The Hong Kong Polytechnic University","startDate":"2024-01-16","conditions":"Dry Eye Syndromes","enrollment":31},{"nctId":"NCT04237012","phase":"PHASE4","title":"ACCURATE Study for Subjects With Dry Eyes","status":"COMPLETED","sponsor":"The Eye Centers of Racine and Kenosha","startDate":"2019-12-16","conditions":"Dry Eye Syndromes","enrollment":30},{"nctId":"NCT06585982","phase":"NA","title":"Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile Analysis","status":"RECRUITING","sponsor":"Universitas Diponegoro","startDate":"2024-03-04","conditions":"Fatty Liver Disease","enrollment":50},{"nctId":"NCT06679322","phase":"PHASE2","title":"The Androtriol Injection for the Treatment of Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-10-31","conditions":"Acute Ischemic Stroke","enrollment":300},{"nctId":"NCT06017362","phase":"PHASE4","title":"Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors","status":"RECRUITING","sponsor":"Barbara Burgos Blasco","startDate":"2023-02-08","conditions":"Dry Eye, Glaucoma","enrollment":100},{"nctId":"NCT03374306","phase":"NA","title":"Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate","status":"COMPLETED","sponsor":"The Hong Kong Polytechnic University","startDate":"2018-02-01","conditions":"Myopia","enrollment":71},{"nctId":"NCT04630158","phase":"PHASE2","title":"Study of Efficacy and Safety of SAF312 Eye Drops in Subjects With Post-operative Corneal Induced Chronic Pain (CICP)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-04-21","conditions":"Chronic Ocular Pain","enrollment":153},{"nctId":"NCT05290727","phase":"NA","title":"Efficacy of \"Aquoral Lipo\" Artificial Tears in Contact Lens Wearers With Discomfort","status":"COMPLETED","sponsor":"Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA","startDate":"2022-03-01","conditions":"Contact Lens Complication","enrollment":41},{"nctId":"NCT06576245","phase":"NA","title":"Efficacy of Quantum Molecular Resonance Combined With Intense Pulsed Light in Mixed Dry Eye","status":"COMPLETED","sponsor":"University of Seville","startDate":"2023-09-01","conditions":"Dry Eye","enrollment":25}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":16,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"artificial tear therapy","genericName":"artificial tear therapy","companyName":"Tianjin Medical University Eye Hospital","companyId":"tianjin-medical-university-eye-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Artificial tear therapy replaces or supplements the eye's natural tear film to lubricate the ocular surface and relieve symptoms of dry eye disease. Used for Dry eye disease (keratoconjunctivitis sicca), Ocular surface irritation and discomfort.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}